• Published On : Dec-2018 |
  • Pages : 173 Pages |
  • Format :

Table of Content

1. Executive Summary
     1.1. Market Overview
     1.2. Market Analysis
     1.3. PMR Analysis and Recommendations
     1.4. Wheel of Fortune

2. Market Introduction
     2.1. Market Taxonomy
     2.2. Market Definition

3. Injectable Nanomedicines Market Opportunity Analysis
     3.1. Macro-Economic Factors
     3.2. Opportunity

4. Market Background
     4.1. Market Dynamics
            4.1.1. Drivers
            4.1.2. Restraints
            4.1.3. Trends

5. Key Inclusions
     5.1. Nanomedicines Development Over Time
     5.2. Regulatory Scenario
     5.3. Disease Epidemiology
     5.4. Approvals of Commercial Injectable Nanomedicines

6. North America Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026
     6.1. Introduction
     6.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            6.2.1. U.S.
            6.2.2. Canada
     6.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     6.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            6.4.1. Liposomes
            6.4.2. Micelles
            6.4.3. Nanocrystals
            6.4.4. Polymeric Nanoparticles
            6.4.5. Metallic Nanoparticles
            6.4.6. Mesoporous Silica Nanoparticles
            6.4.7. Others
     6.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     6.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
            6.6.1. Cancers
            6.6.2. Central Nervous System Diseases
            6.6.3. Cardiovascular diseases
            6.6.4. Infection Control
            6.6.5. Inflammatory Diseases
            6.6.6. Others
     6.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
     6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            6.8.1. Hospitals
            6.8.2. Ambulatory Surgical Centers
            6.8.3. Clinics
            6.8.4. Specialized Drugs R&D Institutes
            6.8.5. Managed Care Organizations
     6.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
     6.10. Market Attractiveness Analysis
            6.10.1. By Country
            6.10.2. By Drug Type
            6.10.3. By Application
            6.10.4. By End User

7. Latin America Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026
     7.1. Introduction
     7.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            7.2.1. Brazil
            7.2.2. Mexico
            7.2.3. Rest of Latin America
     7.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     7.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            7.4.1. Liposomes
            7.4.2. Micelles
            7.4.3. Nanocrystals
            7.4.4. Polymeric Nanoparticles
            7.4.5. Metallic Nanoparticles
            7.4.6. Mesoporous Silica Nanoparticles
            7.4.7. Others
     7.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     7.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
            7.6.1. Cancers
            7.6.2. Central Nervous System Diseases
            7.6.3. Cardiovascular diseases
            7.6.4. Infection Control
            7.6.5. Inflammatory Diseases
            7.6.6. Others
     7.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
     7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            7.8.1. Hospitals
            7.8.2. Ambulatory Surgical Centers
            7.8.3. Clinics
            7.8.4. Specialized Drugs R&D Institutes
            7.8.5. Managed Care Organizations
     7.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
     7.10. Market Attractiveness Analysis
            7.10.1. By Country
            7.10.2. By Drug Type
            7.10.3. By Application
            7.10.4. By End User

8. Europe Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026
     8.1. Introduction
     8.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            8.2.1. Germany
            8.2.2. U.K.
            8.2.3. France
            8.2.4. Italy
            8.2.5. Spain
            8.2.6. Russia
            8.2.7. Rest of Europe
     8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     8.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            8.4.1. Liposomes
            8.4.2. Micelles
            8.4.3. Nanocrystals
            8.4.4. Polymeric Nanoparticles
            8.4.5. Metallic Nanoparticles
            8.4.6. Mesoporous Silica Nanoparticles
            8.4.7. Others
     8.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     8.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
            8.6.1. Cancers
            8.6.2. Central Nervous System Diseases
            8.6.3. Cardiovascular diseases
            8.6.4. Infection Control
            8.6.5. Inflammatory Diseases
            8.6.6. Others
     8.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
     8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            8.8.1. Hospitals
            8.8.2. Ambulatory Surgical Centers
            8.8.3. Clinics
            8.8.4. Specialized Drugs R&D Institutes
            8.8.5. Managed Care Organizations
     8.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
     8.10. Market Attractiveness Analysis
            8.10.1. By Country
            8.10.2. By Drug Type
            8.10.3. By Application
            8.10.4. By End User

9. Asia Pacific Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026
     9.1. Introduction
     9.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            9.2.1. Japan
            9.2.2. China
            9.2.3. India
            9.2.4. Australia and New Zealand
            9.2.5. Rest of Asia Pacific
     9.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     9.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            9.4.1. Liposomes
            9.4.2. Micelles
            9.4.3. Nanocrystals
            9.4.4. Polymeric Nanoparticles
            9.4.5. Metallic Nanoparticles
            9.4.6. Mesoporous Silica Nanoparticles
            9.4.7. Others
     9.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     9.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
            9.6.1. Cancers
            9.6.2. Central Nervous System Diseases
            9.6.3. Cardiovascular diseases
            9.6.4. Infection Control
            9.6.5. Inflammatory Diseases
            9.6.6. Others
     9.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
     9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            9.8.1. Hospitals
            9.8.2. Ambulatory Surgical Centers
            9.8.3. Clinics
            9.8.4. Specialized Drugs R&D Institutes
            9.8.5. Managed Care Organizations
     9.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
     9.10. Market Attractiveness Analysis
            9.10.1. By Country
            9.10.2. By Drug Type
            9.10.3. By Application
            9.10.4. By End User

10. Middle East & Africa Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026
     10.1. Introduction
     10.2. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
            10.2.1. GCC Countries
            10.2.2. South Africa
            10.2.3. Rest of MEA
     10.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
     10.4. Historical Market Value (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            10.4.1. Liposomes
            10.4.2. Micelles
            10.4.3. Nanocrystals
            10.4.4. Polymeric Nanoparticles
            10.4.5. Metallic Nanoparticles
            10.4.6. Mesoporous Silica Nanoparticles
            10.4.7. Others
     10.5. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     10.6. Historical Market Value (US$ Mn) Trend Analysis By Application, 2013–2017
            10.6.1. Cancers
            10.6.2. Central Nervous System Diseases
            10.6.3. Cardiovascular diseases
            10.6.4. Infection Control
            10.6.5. Inflammatory Diseases
            10.6.6. Others
     10.7. Market Size (US$ Mn) Forecast By Application, 2018–2026
     10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            10.8.1. Hospitals
            10.8.2. Ambulatory Surgical Centers
            10.8.3. Clinics
            10.8.4. Specialized Drugs R&D Institutes
            10.8.5. Managed Care Organizations
     10.9. Market Size (US$ Mn) Forecast By End User, 2018–2026
     10.10. Market Attractiveness Analysis
            10.10.1. By Country
            10.10.2. By Drug Type
            10.10.3. By Application
            10.10.4. By End User

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Market Structure Analysis
     13.1. Market Structure by Tier of Companies

14. Competition Analysis
     14.1. Competition Dashboard
     14.2. Company Deep Dive
            14.2.1. Merck & Co., Inc.
                      14.2.1.1. Overview
                      14.2.1.2. Product and Technology Portfolio
                      14.2.1.3. Production Footprint
                      14.2.1.4. Sales Footprint
                      14.2.1.5. Channel Footprint
                      14.2.1.6. Strategy
                                 14.2.1.6.1. Marketing Strategy
                                 14.2.1.6.2. Drug Strategy
                                 14.2.1.6.3. Channel Strategy
            14.2.2. Lupin
            14.2.3. Pacira Pharmaceuticals Inc.
            14.2.4. Celgene Pharmaceutical Co. Ltd.
            14.2.5. Amgen, Inc.
            14.2.6. Janssen Biotech Inc. (Sub. Johnson & Johnson Services, Inc.)
            14.2.7. Pfizer Inc.
            14.2.8. Hoffmann-La Roche Ltd.
            14.2.9. Teva Pharmaceutical Industries Ltd.
            14.2.10. Bausch & Lomb Incorporated.

15. Global Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026, By Region
     15.1. Introduction/Key Findings
     15.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2013–2017
     15.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
            15.3.1. North America
            15.3.2. Latin America
            15.3.3. Europe
            15.3.4. Asia Pacific
            15.3.5. Middle East & Africa
     15.4. Market Attractiveness Analysis By Region

16. Global Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
     16.1. Introduction/Key Findings
     16.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
            16.2.1. Liposomes
            16.2.2. Micelles
            16.2.3. Nanocrystals
            16.2.4. Polymeric Nanoparticles
            16.2.5. Metallic Nanoparticles
            16.2.6. Mesoporous Silica Nanoparticles
            16.2.7. Others
     16.3. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
     16.4. Market Attractiveness Analysis By Drug Type

17. Global Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026, By Application
     17.1. Introduction/Key Findings
     17.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013–2017 Orthopedic Surgery
            17.2.1. Cancers
            17.2.2. Central Nervous System Diseases
            17.2.3. Cardiovascular diseases
            17.2.4. Infection Control
            17.2.5. Inflammatory Diseases
            17.2.6. Others
     17.3. Market Size (US$ Mn) Forecast By Application, 2018–2026
     17.4. Market Attractiveness Analysis By Application

18. Global Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026, By End User
     18.1. Introduction/Key Findings
     18.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013–2017
            18.2.1. Hospitals
            18.2.2. Ambulatory Surgical Centers
            18.2.3. Clinics
            18.2.4. Specialized Drugs R&D Institutes
            18.2.5. Managed Care Organizations
     18.3. Market Size (US$ Mn) Forecast By End User, 2018–2026
     18.4. Market Attractiveness Analysis By End User

19. Global Injectable Nanomedicines Market Analysis 2013–2017 and Forecast 2018–2026
     19.1. Market Value Share Analysis By All Segment
     19.2. Y-o-Y Growth Analysis By All Segment
     19.3. Absolute $ Opportunity

20. Assumptions and Acronyms Used

21. Research Methodology


List of Tables

Table 01: Parameters For Quality And Safety Evaluation Of Nanotechnology-based Medicinal Products For Biomedical Use
Table 02: Commercial Available Injectable Nanomedicines (1/3)
Table 03: Commercial Available Injectable Nanomedicines (2/3)
Table 04: Commercial Available Injectable Nanomedicines  (3/3)
Table 05: North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 06: North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
Table 07: North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 08: North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 09: Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 10: Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
Table 11: Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 12: Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 13: Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 14: Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
Table 15: Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 16: Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 17: Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 18: Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
Table 19: Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 20: Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 21: Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Country
Table 22: Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
Table 23: Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 24: Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User
Table 25: Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Region
Table 26: Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
Table 27: Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By Application
Table 28: Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013–2017 and Forecast 2018–2026, By End User


List of Figures

Figure 01: Injectable Nanomedicines Market Value Share By Region (2018)
Figure 02: Global Injectable Nanomedicines Market Value Share, by Country (2017)
Figure 03: Global Injectable Nanomedicines Market Value Share, by Drug Type (2017)
Figure 04: Global Injectable Nanomedicines Market Value Share, by Application (2017)
Figure 05: Global Injectable Nanomedicines Market Value Share, by End User (2017)
Figure 06: North America Injectable Nanomedicines Market, Snapshot
Figure 07: North America Injectable Nanomedicines Market Value Share, by Country (2017)
Figure 08: North America Injectable Nanomedicines Market Value Share, by Drug Type (2017)
Figure 09: North America Injectable Nanomedicines Market Value Share, by Application (2017)
Figure 10: North America Injectable Nanomedicines Market Value Share, by End User (2017)
Figure 11: North America Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013–2017
Figure 12: North America Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 13: North America Injectable Nanomedicines Market Attractiveness Analysis, By Country
Figure 14: North America Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
Figure 15: North America Injectable Nanomedicines Market Attractiveness Analysis, By Application
Figure 16: North America Injectable Nanomedicines Market Attractiveness Analysis, By End User
Figure 17: Latin America Injectable Nanomedicines Market, Snapshot
Figure 18: Latin America Injectable Nanomedicines Market Value Share, by Country (2017)
Figure 19: Latin America Injectable Nanomedicines Market Value Share, by Drug Type (2017)
Figure 20: Latin America Injectable Nanomedicines Market Value Share, by Application (2017)
Figure 21: Latin America Injectable Nanomedicines Market Value Share, by End User (2017)
Figure 22: Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013–2017
Figure 23: Latin America Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 24: Latin America Injectable Nanomedicines Market Attractiveness Analysis, By Country
Figure 25: Latin America Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
Figure 26: Latin America Injectable Nanomedicines Market Attractiveness Analysis, By Application
Figure 27: Latin America Injectable Nanomedicines Market Attractiveness Analysis, By End User
Figure 28: Europe Injectable Nanomedicines Market, Snapshot
Figure 29: Europe Injectable Nanomedicines Market Value Share, by Country (2017)
Figure 30: Europe Injectable Nanomedicines Market Value Share, by Drug Type (2017)
Figure 31: Europe Injectable Nanomedicines Market Value Share, by Application (2017)
Figure 32: Europe Injectable Nanomedicines Market Value Share, by End User (2017)
Figure 33: Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013–2017
Figure 34: Europe Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 35: Europe Injectable Nanomedicines Market Attractiveness Analysis, By Country
Figure 36: Europe Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
Figure 37: Europe Injectable Nanomedicines Market Attractiveness Analysis, By Application
Figure 38: Europe Injectable Nanomedicines Market Attractiveness Analysis, By End User
Figure 39: Asia Pacific Injectable Nanomedicines Market, Snapshot
Figure 40: Asia Pacific Injectable Nanomedicines Market Value Share, by Country (2017)
Figure 41: Asia Pacific Injectable Nanomedicines Market Value Share, by Drug Type (2017)
Figure 42: Asia Pacific Injectable Nanomedicines Market Value Share, by Application (2017)
Figure 43: Asia Pacific Injectable Nanomedicines Market Value Share, by End User (2017)
Figure 44: Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013–2017
Figure 45: Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 46: Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By Country
Figure 47: Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
Figure 48: Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By Application
Figure 49: Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By End User
Figure 50: Middle East & Africa Injectable Nanomedicines Market, Snapshot
Figure 51: Middle East & Africa Injectable Nanomedicines Market Value Share, by Country (2017)
Figure 52: Middle East & Africa Injectable Nanomedicines Market Value Share, by Drug Type (2017)
Figure 53: Middle East & Africa Injectable Nanomedicines Market Value Share, by Application (2017)
Figure 54: Middle East & Africa Injectable Nanomedicines Market Value Share, by End User (2017)
Figure 55: Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013–2017
Figure 56: Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 57: Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By Country
Figure 58: Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
Figure 59: Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By Application
Figure 60: Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By End User
Figure 61: Global Injectable Nanomedicines Market Attractiveness Analysis, By Region
Figure 62: Global Injectable Nanomedicines Market Value Share Analysis, By Region, 2017 & 2026
Figure 63: Global Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
Figure 64: Global Injectable Nanomedicines Market Value Share Analysis, By Drug Type, 2017 & 2026
Figure 65: Global Injectable Nanomedicines Market Attractiveness Analysis, By Application
Figure 66: Global Injectable Nanomedicines Market Value Share Analysis, By Application, 2017 & 2026
Figure 67: Global Injectable Nanomedicines Market Attractiveness Analysis, By End User
Figure 68: Global Injectable Nanomedicines Market Value Share Analysis, By End User, 2017 & 2026
Figure 69: Global Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013–2017
Figure 70: Global Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 71: Global Injectable Nanomedicines Market Absolute $ Opportunity, 2013–2026